The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 15, 2026
Filed:
Nov. 04, 2021
Merck Sharp & Dohme Llc, Rahway, NJ (US);
David A. Candito, Wrentham, MA (US);
Joanna L. Chen, Braintree, MA (US);
Anthony Donofrio, Cambridge, MA (US);
Xavier Fradera, Boston, MA (US);
Peter H. Fuller, Ashland, MA (US);
Shuhei Kawamura, Cambridge, MA (US);
Bing Li, Towaco, NJ (US);
Jongwon Lim, Lexington, MA (US);
Ping Liu, Westfield, NJ (US);
Joey L. Methot, Westwood, NJ (US);
Anilkumar G. Nair, Morganville, NJ (US);
Alexander Pasternak, Jamaica Plain, MA (US);
Brandon A. Vara, Boston, MA (US);
Elsie C. Yu, Brighton, MA (US);
Merck Sharp & Dohme LLC, Rahway, NJ (US);
Abstract
Compounds of the following formula (I); or the pharmaceutically acceptable salts thereof, are inhibitors of haematopoietic progenitor kinase 1 (HPK1) useful in the treatment of diseases or disorders associated with HPK1. Also disclosed herein are uses of these compounds in the potential treatment or prevention of an HPK1-associated disease or disorder. Also disclosed herein are compositions comprising one or more of the compounds. Further disclosed herein are uses of these compositions in the potential prevention or treatment of an HPK1-associated disease or disorder.